Journal of Medicinal Chemistry p. 4052 - 4060 (1993)
Update date:2022-08-04
Topics:
Yamaguchi
Kamei
Koga
Akima
Kuroki
Ohi
A number of 4-substituted 2-[ω-(1-imidazolyl)alkyl]-1(2H)-phthalazinones were synthesized in order to develop agents possessing both thromboxane A2 synthetase inhibitory and bronchodilatory activities. The pharmacological evaluation of these compounds disclosed that they have both activities to various extents. Both activities were slightly dependent on the length of the 2-substituents and largely affected by the nature of the 4-substituents. Compounds bearing phenyl and thienyl groups exhibited relatively high and well-rounded activities. Among these compounds, 12j and 15f were found to be the most effective agents having well-rounded activities in vitro and in vivo. Introduction of a carboxyl group reduced both activities contrary to our expectation. 4-(3-Pyridyl)phthalazinone 18b was of particular interest because of unexpectedly high in vivo activities in spite of an absence of significant in vitro activities.
View MoreTIANJIN DONGRUXIANG MINERALS MARKETING CO.,LTD
Contact:22-58516360
Address:tianjin
Tianjin Bright Future Technology Co., Ltd
Contact:0086-22-58016666
Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
Xinji City Taida Sinopec Co., Ltd.
Contact:0086-311-85341278
Address:No.6, Nanhua Road,Xinji City Road,Hebei Province,China
Contact:86-513-84128750/13773795976
Address:No.48.Youyi West Road ,Rudong Development Zone,Jiangsu Province,China
Zhejiang Allied Chemical Co.,Ltd
Contact:18967038207
Address:Area A-30, High-tech Industrial Park, Quzhou, Zhejiang, China.
Doi:10.1021/acs.jmedchem.9b02121
(2020)Doi:10.1007/BF00529887
(1993)Doi:10.1080/00945719608004347
(1996)Doi:10.1039/c3cc47455k
(2014)Doi:10.1016/S0040-4039(00)61447-8
(1993)Doi:10.1016/S0022-1139(00)85155-6
(1980)